Minimal incidence of serum antibodies reactive with intact primary isolate virions in human immunodeficiency virus type 1-infected individuals
about
Overcoming the Constraints of Anti-HIV/CD89 Bispecific Antibodies That Limit Viral InhibitionAntibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heteroloHumoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques.Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425A1g8.N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus.The v3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope.Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course.Topological analysis of HIV-1 glycoproteins expressed in situ on virus surfaces reveals tighter packing but greater conformational flexibility than for soluble gp120.A bispecific antibody composed of a nonneutralizing antibody to the gp41 immunodominant region and an anti-CD89 antibody directs broad human immunodeficiency virus destruction by neutrophils.
P2860
Q28831255-B9E2A0B9-2897-4470-A6F7-0C1C244DE445Q35024202-6846EE45-87B3-4901-BE49-526CD96E59B8Q35648017-07D720AB-9292-4EFB-9B28-57B6BD026B9EQ36487349-07539FE6-0F3D-493E-BB73-2F14F089FDD8Q36565090-9339B7BF-CE69-4EAD-A50F-A73A7D9C408DQ36954472-A4C38EA0-C9FE-4E0E-A725-AB60DACF9713Q39605628-60CC8126-8374-4B7A-8FC7-73E17C3C51A4Q42572387-F1B3BF63-C7E9-4DBB-B246-6E63B37E284FQ43112430-0495560D-19C6-4380-A240-DCA04ADE05E3
P2860
Minimal incidence of serum antibodies reactive with intact primary isolate virions in human immunodeficiency virus type 1-infected individuals
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Minimal incidence of serum ant ...... us type 1-infected individuals
@ast
Minimal incidence of serum ant ...... us type 1-infected individuals
@en
type
label
Minimal incidence of serum ant ...... us type 1-infected individuals
@ast
Minimal incidence of serum ant ...... us type 1-infected individuals
@en
prefLabel
Minimal incidence of serum ant ...... us type 1-infected individuals
@ast
Minimal incidence of serum ant ...... us type 1-infected individuals
@en
P2093
P2860
P1433
P1476
Minimal incidence of serum ant ...... us type 1-infected individuals
@en
P2093
J E Peterson
L A Cavacini
M R Posner
R Goldstein
P2860
P304
P577
1999-11-01T00:00:00Z